title: Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
authors.affiliation: Blood Centers of the Pacific, Irwin Center, San Francisco, CA 94118, USA. mpbusch@itsa.ucsf.edu
authors.forename: M P
authors.initials: MP
authors.lastname: Busch
authors.forename: L H
authors.initials: LH
authors.lastname: Tobler
authors.forename: G
authors.initials: G
authors.lastname: Tegtmeier
authors.forename: A
authors.initials: A
authors.lastname: Polito
authors.forename: S
authors.initials: S
authors.lastname: Quan
authors.forename: N V
authors.initials: NV
authors.lastname: Hirschler
authors.forename: J
authors.initials: J
authors.lastname: Dockter
authors.forename: C
authors.initials: C
authors.lastname: Giachetti
authors.forename: L
authors.initials: L
authors.lastname: Mimms
mesh_terms: D001782:Blood Donors; D016174:Hepacivirus / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015151:Immunoblotting / Q000379:methods*; D007124:Immunoenzyme Techniques; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins
chemical_list: D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins